Free Access
Med Sci (Paris)
Volume 24, Number 5, Mai 2008
Page(s) 525 - 528
Section M/S revues
Published online 15 May 2008
  1. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155 : 1151–64. [Google Scholar]
  2. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299 : 1057–61. [Google Scholar]
  3. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4 : 330–6. [Google Scholar]
  4. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198 : 1875–86. [Google Scholar]
  5. Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19 : 345–54. [Google Scholar]
  6. Ueno H, Klechevsky E, Morita R, et al. Dendritic cell subsets in health and disease. Immunol Rev 2007; 219 : 118–42. [Google Scholar]
  7. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5 : 296–306. [Google Scholar]
  8. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315 : 107–11. [Google Scholar]
  9. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008; 19 : 3–19. [Google Scholar]
  10. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147 : 258–67. [Google Scholar]
  11. Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci 1957; 147 : 268–73. [Google Scholar]
  12. Ferbas JJ, Toso JF, Logar AJ, et al. CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol 1994; 152 : 4649–62. [Google Scholar]
  13. Sapoznikov A, Fischer JA, Zaft T, et al. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J Exp Med 2007; 204 : 1923–33. [Google Scholar]
  14. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 2006; 12 : 214–9. [Google Scholar]
  15. Chan CW, Crafton E, Fan HN, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006; 12 : 207–13. [Google Scholar]
  16. Bonmort M, Dalod M, Mignot G, et al. Killer dendritic cells: IKDC and the others. Curr Opin Immunol 2008 (sous presse). [Google Scholar]
  17. Blasius AL, Barchet W, Cella M, Colonna M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 2007; 204 : 2561–8. [Google Scholar]
  18. Caminschi I, Ahmet F, Heger K, et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med 2007; 204 : 2579–90. [Google Scholar]
  19. Vosshenrich CA, Lesjean-Pottier S, Hasan M, et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007; 204 : 2569–78. [Google Scholar]
  20. Spits H, Lanier LL. Natural killer or dendritic: what’s in a name ? Immunity 2007; 26 : 11–6. [Google Scholar]
  21. Ullrich E, Bonmort M, Mignot G, et al. Trans-presentation of interleukin-15 dictates IKDC effector functions. 2008 (sous presse). [Google Scholar]
  22. Welner RS, Pelayo R, Garrett KP, et al. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood 2007; 109 : 4825–31. [Google Scholar]
  23. Mignot G, Ullrich E, Bonmort M, et al. The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2. J Immunol 2008 (sous presse). [Google Scholar]
  24. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176 : 1517–24. [Google Scholar]
  25. Ullrich E. Boston : Federation of Clinical Immunology Societies (FOCIS), 2008. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.